Comparison of Oestrogen Receptor, Progesterone Receptor, and Human Epiderman Growth Factor Receptor-2 Expression in Primary Breast Cancer and Lymph Node Metastasis at the Korle-Bu Teaching Hospital, Accra, Ghana
作者： B.A. Mawuli
DOI:
关键词:
摘要:
参考文章(158)
McCarty Ks, Steroid hormone receptors in the regulation of differentiation. A review. American Journal of Pathology. ,vol. 86, pp. 705- 744 ,(1977)
Kapil Dhingra, Antiestrogens--tamoxifen, SERMs and beyond. Investigational New Drugs. ,vol. 17, pp. 285- 311 ,(1999) , 10.1023/A:1006348907994
Stacy M. Cowherd, Tumor Staging and Grading: A Primer Methods of Molecular Biology. ,vol. 823, pp. 1- 18 ,(2012) , 10.1007/978-1-60327-216-2_1
William Jacot, Stéphane Pouderoux, Frédéric Bibeau, Cristina Leaha, Marie-Christine Chateau, Angélique Chapelle, Gilles Romieu, Variation d’expression des récepteurs hormonaux et d’HER-2 dans l’évolution du cancer du sein : quelles implications en pratique clinique ? Bulletin du Cancer. ,vol. 98, pp. 1059- 1070 ,(2011) , 10.1684/BDC.2011.1434
Francesca Rastelli, Sergio Crispino, Factors predictive of response to hormone therapy in breast cancer. Tumori. ,vol. 94, pp. 370- 383 ,(2008) , 10.1177/030089160809400314
AB Mitra, VVVS Murty, Mahendra Pratap, P Sodhani, RSK Chaganti, None, ERBB2 (HER2/neu) Oncogene Is Frequently Amplified in Squamous Cell Carcinoma of the Uterine Cervix Cancer Research. ,vol. 54, pp. 637- 639 ,(1994)
Edwin K Wiredu, Henry B Armah, Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality BMC Public Health. ,vol. 6, pp. 159- 159 ,(2006) , 10.1186/1471-2458-6-159
Rebecca B. Riggins, Amy H. Bouton, Minetta C. Liu, Robert Clarke, Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. Vitamins and Hormones Series. ,vol. 71, pp. 201- 237 ,(2005) , 10.1016/S0083-6729(05)71007-4
P. Kastner, A. Krust, B. Turcotte, U. Stropp, L. Tora, H. Gronemeyer, P. Chambon, Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. The EMBO Journal. ,vol. 9, pp. 1603- 1614 ,(1990) , 10.1002/J.1460-2075.1990.TB08280.X
Mark M. Moasser, Steven D. Averbuch, Neal Rosen, Andrea Basso, The Tyrosine Kinase Inhibitor ZD1839 ("Iressa") Inhibits HER2-driven Signaling and Suppresses the Growth of HER2-overexpressing Tumor Cells Cancer Research. ,vol. 61, pp. 7184- 7188 ,(2001)